OncoCyte Corporation (NASDAQ:OCX) Q3 2021 Earnings Conference Call November 9, 2021 4:30 PM ET Company Participants Bob Yedid – LifeSci Advisors, LLC Ronnie Andrews – President and Chief Executive Officer Mitch Levine – Chief Financial Officer Doug Ross – Chief Science Officer Padma Sundar – Chief Commercial Officer Conference Call Participants Paul Knight – KeyBanc Mark Massaro – BTIG Joseph Stringer – Needham Bruce Jackson – Benchmark Company Operator Greetings, and welcome to the Oncocyte Corporation Thi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to __________ Oncocyte Corporation (Exact name of registrant as specified in its charter) California 27-1041563 (State or other jurisdiction of incorpora ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to __________ Commission file number 1-37648 Oncocyte Corporation (Exact name of registrant as specified in its charter) (State or other jurisdiction of incor ...

Oncocyte Corporation (NASDAQ:OCX) Q2 2021 Earnings Conference Call August 10, 2021 4:30 PM ET Company Participants Bob Yedid - IR, LifeSci Advisors, LLC Ronnie Andrews - President and CEO Mitch Levine - CFO Padma Sundar - Chief Commercial Officer Conference Call Participants Mike Matson - Needham & Company Thomas Flaten - Lake Street Operator Greetings, and welcome to Oncocyte Corporation Second Quarter 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-a ...

OncoCyte Corporation (NASDAQ:OCX) Q1 2021 Results Conference Call May 17, 2021 4:30 PM ET Company Participants Bob Yedid - IR, LifeSci Advisors, LLC Ronnie Andrews - President and CEO Mitch Levine - CFO Dr. Doug Ross - Chief Science Officer Padma Sundar - Chief Commercial Officer Conference Call Participants Mike Matson - Needham & Company Mark Massaro - BTIG Thomas Flaten - Lake Street Steven Mah - Piper Sandler Paul Knight - KeyBanc Bruce Jackson - Benchmark Operator Good afternoon, ladies and gentlemen, ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to __________ Commission file number 1-37648 OncoCyte Corporation (Exact name of registrant as specified in its charter) (State or other jurisdiction of inco ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Commission file number 1-37648 OncoCyte Corporation FORM 10-K (Exact name of registrant as specified in its charter) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (State or other jurisdiction of incorporation or organization) For the fiscal year ended December 31, 2020 California 27-1041563 (I.R.S. Employer Identification No.) OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITI ...

Investor Presentation Q1 2021 HONCOCYTE® Where Tomorrow LIVES Forward Looking Statement Oncocyte Forward Looking Statements. Oncocyte cautions you that this press release contains forward-looking statements. Any statements that are not historical fact (including, but not limited to statements that contain words such as "will," "believes," "plans," "anticipates," "expects," "estimates," "may," and similar expressions) are forward-looking statements. These statements include those pertaining to the acquisitio ...

Oncocyte Corporation (NASDAQ:OCX) Q4 2020 Results Conference Call March 16, 2021 4:30 PM ET Company Participants Bob Yedid - IR, LifeSci Advisors, LLC Ronnie Andrews - President and CEO Mitch Levine - CFO Dr. Doug Ross - Chief Science Officer Padma Sundar - Chief Commercial Officer Conference Call Participants Mike Matson - Needham & Company Mark Massaro - BTIG Steven Mah - Piper Sandler Thomas Flaten - Lake Street Capital Markets Bruce Jackson - Benchmark Company Paul Knight - KeyBanc Operator Greetings, a ...

Investor Presentation Q4 2020 HONCOCYTE® Where Tomorrow LIVES 1 | --- | |------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...